Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New developments in molecularbiological diagnostic].

Christine Mannhalter1

  • 1Christine Mannhalter, Medical University Vienna - Department of Laboratory Medicine, Währinger Gürtel 18, Wien, Österreich, Tel: 0043/1/40400-2085, Fax: 0043/1/40400-2097,

Hamostaseologie
|April 14, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation.

Platelets·2022
Same author

Ex Vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small Interfering RNA.

Thrombosis and haemostasis·2020
Same author

Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.

Clinical chemistry and laboratory medicine·2020
Same author

Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.

Annals of surgery·2018
Same author

Phenotyping and Target Expression Profiling of CD34<sup>+</sup>/CD38<sup>-</sup> and CD34<sup>+</sup>/CD38<sup>+</sup> Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.

Neoplasia (New York, N.Y.)·2018
Same author

Impact-Faktor 2011 = 1,190.

Hamostaseologie·2018
Same journal

Update: Immune Tolerance Induction Practice in Haemophilia.

Hamostaseologie·2026
Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026
Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
Same journal

Hamostaseologie·2026
See all related articles

Advanced molecular methods like PCR, Sanger sequencing, and next-generation sequencing (NGS) are crucial for genotyping. Quality control and data challenges are key considerations for their widespread diagnostic application.

Area of Science:

  • Molecular Biology
  • Genetics
  • Bioinformatics

Background:

  • Molecular methods are essential for various applications, including disease diagnosis, forensic analysis, and evolutionary studies.
  • Quality control of both methods and laboratories is critical for reliable molecular testing.

Purpose of the Study:

  • To discuss the quality control aspects of molecular methods and laboratories.
  • To review current genotyping techniques and their applications.
  • To highlight the emerging role and challenges of next-generation sequencing (NGS) in diagnostics.

Main Methods:

  • Polymerase Chain Reaction (PCR) analysis
  • Sanger sequencing
  • Next-Generation Sequencing (NGS)
Keywords:
Molecular diagnosticsmolecular analysesnext generation sequencingquality issues

Related Experiment Videos

Main Results:

  • PCR and Sanger sequencing are currently standard for diagnostics.
  • NGS is becoming increasingly feasible due to decreased costs (approx. USD 1000), but faces challenges in data processing and storage.
  • Understanding the clinical relevance of polymorphisms is crucial for personalized medicine.

Conclusions:

  • The choice of genotyping method depends on mutation type and heterogeneity.
  • NGS is poised for broader clinical adoption, pending solutions for data management.
  • Further research is needed to interpret the clinical significance of genetic polymorphisms.